Lobbying Filing Details

Total Spending

$40,000

Activities

1

Lobbyists

2

Gov't Entities

5

Filing Information
Filing UUID:
2a383938-e72f-4586-9141-868054896ef7
Type:
Q1 - 1st Quarter - Report
Period:
2026 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 17, 2026 at 1:04 PM
Income:
$40,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Beth Anne Cole
Registrant
MARSHALL & POPP, LLC

​Government affairs and consulting firm.

Washington, District of Columbia
Client
SUN PHARMACEUTICAL INDUSTRIES, INC.

Biopharmaceutical manufacturer.

New Jersey, United States of America
Lobbying Activities (1)
Activity 1
Pharmacy

Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.

Lobbyists (2)
  • MONICA POPP
  • HAZEN CLAY MARSHALL
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
  • Food & Drug Administration (FDA)
  • Centers For Medicare and Medicaid Services (CMS)

Source: LDA.gov, data retrieved November 11, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.